ConductScience.org, home

Paper · 41895280

Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.

Bandlamudi C and 88 others. Cancer Cell, 2026. Cited by 4 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Cancer type-specific variation in patterns of driver alterations across 50,000 tumors. Papers, record 41895280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41895280

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.
PubMed
Journal
Cancer Cell
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-10-22
PubMed

Authors89

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bandlamudi CChaitanya
2Muldoon DDaniel
3de Bruijn IIno
4Zhang MMingxuan
5Gormally MVMichael V
6Harrold ECEmily C
7Nandakumar SSubhiksha
8Smith SAShaleigh A
9Jeng MYMark Y
10Woods SSydney

1 to 10 of 89Source PubMed

See all 89 authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
MutationMajor topic
Humans
HLA Antigens

Source PubMed

Grants12

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P50 CA272170NCI NIH HHSUnited StatesP50CA272170PubMedNIH RePORTER
U24 CA220457NCI NIH HHSUnited StatesU24CA220457PubMedNIH RePORTER
R35 CA305347NCI NIH HHSUnited StatesR35CA305347PubMedNIH RePORTER
R01 CA286507NCI NIH HHSUnited StatesR01CA286507PubMedNIH RePORTER
R01 CA227534NCI NIH HHSUnited StatesR01CA227534PubMedNIH RePORTER
R25 CA233208NCI NIH HHSUnited StatesR25CA233208PubMedNIH RePORTER
P50 CA221745NCI NIH HHSUnited StatesP50CA221745PubMedNIH RePORTER
R35 NS105109NINDS NIH HHSUnited StatesR35NS105109PubMedNIH RePORTER
P50 CA257881NCI NIH HHSUnited StatesP50CA257881PubMedNIH RePORTER
R35 CA263816NCI NIH HHSUnited StatesR35CA263816PubMedNIH RePORTER

1 to 10 of 12

See all 12 grants

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in42,001,850Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.https://conductscience.org/library/papers/42001850

Source PubMed

References92

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139,670,006EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer.Transl Lung Cancer Res2024https://conductscience.org/library/papers/39670006PubMed
231,839,416Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib.Lung Cancer2020https://conductscience.org/library/papers/31839416PubMed
333,625,877OncoTree: A Cancer Classification System for Precision Oncology.JCO Clin Cancer Inform2021https://conductscience.org/library/papers/33625877PubMed
418,772,396An integrated genomic analysis of human glioblastoma multiforme.Science2008https://conductscience.org/library/papers/18772396PubMed
52,188,735A genetic model for colorectal tumorigenesis.Cell1990https://conductscience.org/library/papers/2188735PubMed
639,602,136Next-Generation Sequencing for HLA Genotype Screening and Matching to HLA-Restricted Therapies.JAMA Oncol2025https://conductscience.org/library/papers/39602136PubMed
730,872,507Tissue-specificity in cancer: The rule, not the exception.Science2019https://conductscience.org/library/papers/30872507PubMed
832,025,013The evolutionary history of 2,658 cancers.Nature2020https://conductscience.org/library/papers/32025013PubMed
923,348,506Highly recurrent TERT promoter mutations in human melanoma.Science2013https://conductscience.org/library/papers/23348506PubMed
1027,270,079FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing.Nucleic Acids Res2016https://conductscience.org/library/papers/27270079PubMed

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn Papers
42,353,852Domain-Level Distribution of Pathogenic BRCA1/2 Somatic Mutations Shows No Evidence of Large Subtype-Specific Enrichment in Breast Cancer: A Three-Cohort Analysis Supporting Broad BRCA Testing.Genes (Basel)2026https://conductscience.org/library/papers/42353852

Source PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41895280

GET https://conductscience.org/api/papers/v1/41895280/authors?page=2